The Beat Childhood Cancer research consortium is a group of 40+ universities and children's hospitals that offer a worldwide network of childhood cancer clinical trials coordinated by Helen DeVos Children’s Hospital.
Beat Childhood Cancer has a proven track record of managing multi-site clinical trials from start to finish. We have successfully opened nineteen Phase I and II trials for pediatric cancer patients including four Feasibility trials using Molecular Guided Therapy in children with relapsed cancers. Six Phase I/II trials have been completed to date and are published or in submission for publication.
Beat Childhood Cancer has successfully managed four FDA approved IND applications, two FDA approved IDE applications, as well as multiple FDA approved EIND applications.
|Giselle Sholler, MD||Chair, Beat Childhood Cancer|
|Patrick Lacey||Executive Advisor | Founder, Beat Nb|
|William Ferguson, MD||Cardinal Glennon Children’s Medical Center
Saint Louis University School of Medicine
|Jaqueline Kraveka, DO||Medical University of South Carolina|
|Genevieve Bergendahl, PNP, MSN, CCRP||Clinical Program Director, Beat Childhood Cancer|